Michael Lewis on Heather Stone of the Food and Drug Administration. Heather Stone, a science policy analyst for the Food and Drug Administration's Center for Drug Evaluation and Research ...

Food and Drug Administration officials have told some scientists and inspections staff that their layoffs will be reversed, after the job cuts led to disruptions in drug and food safety work.

He covers federal public health agencies. Senior Food and Drug Administration leaders are planning for cutbacks to the number of routine food and drug inspections conducted by the agency ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...

Kennedy Jr. together with U.S. Food and Drug Administration (FDA) Commissioner Dr. Mary Makary announced a new round of food dye bans on Tuesday at a press conference. The agencies shared their ...

The Trump administration has fired Food and Drug Administration employees responsible for the federal response to the ongoing bird flu outbreaks, according to former staff and professional groups.

The Food and Drug Administration laid out these inspection findings in warning letters, accusing the companies of committing “significant violations” of federal laws, according to an FDA staff ...

Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has designated the HADLIMA™ (adalimumab-bwwd) high- and low-concentration ...

When Health and Human Services Secretary Robert F. Kennedy Jr. announced in March that he would eliminate thousands of jobs from federal health agencies, he promised that he would spare the ...

Biotech companies developing drugs for hard-to-treat diseases and other ailments are being forced to push back clinical trials and drug testing ... layoffs at the Food and Drug Administration.

April 10 (UPI) --The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and ...